Does Type 1 Diabetes in Adulthood Elevate Cardiovascular Disease and Mortality Risk?

Synopsis
Key Takeaways
- Adult-onset type 1 diabetes increases cardiovascular disease risk.
- Patients diagnosed later do not have better outcomes than earlier diagnoses.
- Smoking, obesity, and poor glucose control are key risk factors.
- Further research is needed to optimize treatment strategies.
- The seriousness of this condition persists even when diagnosed in adulthood.
New Delhi, May 14 (NationPress) Individuals diagnosed with type 1 diabetes in adulthood face a heightened risk of cardiovascular diseases and mortality, as revealed by recent research.
Interestingly, those who receive a diagnosis later in life do not exhibit a more favorable prognosis than their counterparts diagnosed earlier in life. This study, conducted by researchers at Karolinska Institutet in Sweden, highlighted smoking, poor glucose management, and obesity as significant contributors to these risks.
Due to the limited research on adult-onset type 1 diabetes, the research team aimed to explore the cardiovascular disease risk and mortality rates among patients diagnosed post-40 years of age.
The findings, published in the European Heart Journal, analyzed data from 10,184 individuals diagnosed with type 1 diabetes in adulthood between 2001 and 2020 and compared them with 509,172 matched controls.
The study indicates that individuals with adult-onset type 1 diabetes have a greater likelihood of experiencing cardiovascular issues and death from various causes, including cancers and infections, relative to the control group.
Yuxia Wei, a postdoctoral fellow at the Institute of Environmental Medicine, Karolinska Institutet, noted that the primary factors contributing to the unfavorable prognosis include smoking, overweight/obesity, and inadequate glucose control.
“We discovered that these individuals were less inclined to utilize assistive devices, such as insulin pumps,” Wei remarked.
The research team intends to delve deeper into adult-onset type 1 diabetes, examining risk factors associated with the disease and the prognosis for other outcomes like microvascular complications. Optimal treatment strategies for adult-onset type 1 diabetes, including the impact of pump usage and advanced technologies, also warrant further investigation.
The study received funding from the Swedish Research Council and the Swedish Diabetes Foundation, among others, with researchers declaring no conflicts of interest.
These results underscore the seriousness of type 1 diabetes, even when it manifests later in life, as emphasized by the research team.